Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.
Zhao L, Ren Y, Zhang G, Zheng K, Wang J, Sha H, Zhao M, Huang R, Kang D, Su X, Wu Y, Zhang W, Lai R, Li L, Mei R, Wang Y, Tian Y, Wang F, Liu B, Zou Z.
Zhao L, et al. Among authors: huang r.
J Immunother Cancer. 2024 Jun 21;12(6):e008611. doi: 10.1136/jitc-2023-008611.
J Immunother Cancer. 2024.
PMID: 38908858
Free article.
Clinical Trial.